Flumatinib Mesylate | Interleukin Related interleukin-related.com

Product Name :
Flumatinib Mesylate

Search keywords :
Flumatinib

drugId :
null

Target Vo:
Bcr-Abl tyrosine kinase

Target Vo Short Name :
Bcr-Abl

Moa_Name:
Bcr-Abl tyrosine kinase inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:
2019

Origin Company_Name :
Jiangsu Hansoh Pharmaceutical Group Co Ltd

Active Company_Name :
Jiangsu Hansoh Pharmaceutical Group Co Ltd

Active Indication_Name:
Leukemia, Myelogenous, Chronic

In Active Indication_Name:
Leukemia, Myeloid, Chronic-Phase

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TWIST Antibody Biological Activity
STAT3 Rabbit mAb Data Sheet
Integrin beta 1 Antibody: Integrin beta 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to Integrin beta 1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts